Vanguard Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Vanguard Capital Management's IONS Position: Q3 2026 in Review
Vanguard Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 0.1% in Q3 2026, buying an estimated $400K and bringing the position to 7,218,530 shares worth $322M. The position accounts for 0.01% of the portfolio, ranked #846.
Vanguard Capital Management first reported a position in IONS in Q1 2026 and has held it in 3 quarters since. The position peaked at $572M in Q2 2026. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Vanguard Capital Management held 7,218,530 shares of Ionis Pharmaceuticals worth $322M as of Q3 2026.
- Vanguard Capital Management bought 7,033 Ionis Pharmaceuticals shares in Q3 2026, an estimated $400K.
- Ionis Pharmaceuticals made up 0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #846 holding.
- Vanguard Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Ionis Pharmaceuticals position peaked at $572M in Q2 2026.
- 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.